Conversely, those experiencing significant hyperglycaemia may need to resume Ozempic sooner, balanced against surgical recovery considerations
1 Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently one of the most important public health issues in the world because it is directly related to metabolic disorders such as obesity, insulin resistance, and type 2 diabetes mellitus (T2DM) ( MASLD is particularly notorious for being able to accelerate the development of T2DM, a chronic metabolic disease characterized by hyperglycemia, IR, and beta cell failure ( The main pathophysiological mechanisms through which Insulin resistance (IR), hepatic lipid accumulation, and low-grade inflammation lead to MASLD and T2DM have been described ( 2 Epidemiological data With the prevention and control of many infectious diseases, Non-Communicable Diseases (NCDs) have become the leading global diseases burden (32)

However, their findings have been critically questioned due to methodological limitations, including potential residual confounding, lack of dose and duration adjustment, absence of glycemic control data, and the biological implausibility of observing AD risk reduction within weeks of treatment initiation 83,84
Participants also showed improvements in cardiovascular risk factors, including waist circumference, non-HDL cholesterol, triglycerides, systolic blood pressure, and high-sensitivity C-reactive protein (hsCRP)
Legumes: Lentils, chickpeas, and black beans are packed with fiber
People who take this drug can start to lose weight in as little as four weeks, but more research is needed